- Home
- Publications
- Publication Search
- Publication Details
Title
Developments of CRBN-based PROTACs as potential therapeutic agents
Authors
Keywords
PROTACs, Ubiquitination, CRBN, Degradation, Promising treatment
Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 225, Issue -, Pages 113749
Publisher
Elsevier BV
Online
2021-08-10
DOI
10.1016/j.ejmech.2021.113749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development of a Hematopoietic Prostaglandin D Synthase-Degradation Inducer
- (2021) Hidetomo Yokoo et al. ACS Medicinal Chemistry Letters
- Discovery of Thalidomide-based PROTAC Small Molecules as the Highly Efficient SHP2 Degraders
- (2021) Xiangbo Yang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Structure-Based Discovery of SIAIS001 as an Oral Bioavailability ALK Degrader Constructed from Alectinib
- (2021) Chaowei Ren et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems
- (2021) Xiaojuan Qu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a PROTAC targeting ALK with in vivo activity
- (2021) Guoyi Yan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of EZH2-Based PROTACs to Degrade the PRC2 Complex for Targeting the Noncatalytic Activity of EZH2
- (2021) Zhihao Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91
- (2021) Maha Hanafi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy
- (2021) Liguo Wang et al. Nature Chemical Biology
- Synergistic short-term and long-term effects of TGF-β1 and 3 on collagen production in differentiating myoblasts
- (2021) Andi Shi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Novel PROTACs for degradation of SHP2 protein
- (2021) Mengzhu Zheng et al. BIOORGANIC CHEMISTRY
- Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer
- (2021) Linrong Chen et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog–Thalidomide PROTACs
- (2021) Ga Yeong Kim et al. MOLECULES
- Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
- (2021) Hannah M. King et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and linkage optimization of ursane-thalidomide-based PROTACs and identification of their targeted-degradation properties to MDM2 protein
- (2021) Zhiwen Qi et al. BIOORGANIC CHEMISTRY
- In vitro and in vivo degradation of programmed cell death ligand 1 (PD-L1) by a proteolysis targeting chimera (PROTAC)
- (2021) Yubo Wang et al. BIOORGANIC CHEMISTRY
- Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries
- (2021) Bo Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A biphenyl inhibitor of eIF4E targeting an internal binding site enables the design of cell-permeable PROTAC-degraders
- (2021) Patrick D. Fischer et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective inhibition of Ph-positive ALL cell growth through kinase-dependent and independent effects by CDK6-specific PROTACs
- (2020) Marco De Dominici et al. BLOOD
- Design and synthesis of α-naphthoflavone chimera derivatives able to eliminate cytochrome P450 (CYP)1B1-mediated drug resistance via targeted CYP1B1 degradation
- (2020) Li Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)
- (2020) Hao Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Potent and Selective Epidermal Growth Factor Receptor (EGFR) Bifunctional Small-Molecule Degraders
- (2020) Meng Cheng et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTACs: A novel strategy for cancer therapy
- (2020) Jing Liu et al. SEMINARS IN CANCER BIOLOGY
- Discovery of the first potent proteolysis targeting chimera (PROTAC) degrader of indoleamine 2, 3-dioxygenase 1
- (2020) Mingxing Hu et al. Acta Pharmaceutica Sinica B
- First small-molecule PROTACs for G protein-coupled receptors: Inducing α1A-adrenergic receptor degradation
- (2020) Zhenzhen Li et al. Acta Pharmaceutica Sinica B
- Targeted degradation of anaplastic lymphoma kinase by gold nanoparticle-based multi-headed proteolysis targeting chimeras
- (2020) Yingming Wang et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- Discovery of PROTAC BCL-XL degraders as potent anticancer agents with low on-target platelet toxicity
- (2020) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- Azo-PROTAC: Novel Light-Controlled Small-Molecule Tool for Protein Knockdown
- (2020) Yu-Hui Jin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Degradation versus Inhibition: Development of Proteolysis-Targeting Chimeras for Overcoming Statin-Induced Compensatory Upregulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase
- (2020) Mei-Xin Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of Proteolysis Targeting Chimeras (PROTACs) for the Dual Degradation of IGF-1R and Src
- (2020) Sudhakar Manda et al. MOLECULES
- A Chemical Switch System to Modulate Chimeric Antigen Receptor T Cell Activity through Proteolysis-Targeting Chimaera Technology
- (2020) So Myoung Lee et al. ACS Synthetic Biology
- Tubulin Resists Degradation by Cereblon-Recruiting PROTACs
- (2020) Ivana Gasic et al. Cells
- Discovery and biological evaluation of proteolysis targeting chimeras (PROTACs) as an EGFR degraders based on osimertinib and lenalidomide
- (2020) Kailun He et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of small-molecule BRD4 degraders based on pyrrolopyridone derivative
- (2020) Jian Zhang et al. BIOORGANIC CHEMISTRY
- Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1
- (2020) Binbin Cheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Global PROTAC Toolbox for Degrading BCR–ABL Overcomes Drug-Resistant Mutants and Adverse Effects
- (2020) Yiqing Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Correction to Efficient Targeted Degradation via Reversible and Irreversible Covalent PROTACs
- (2020) Ronen Gabizon et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Functional characterization of a PROTAC directed against BRAF mutant V600E
- (2020) Ganna Posternak et al. Nature Chemical Biology
- A Phase II Trial of Alisertib ( MLN8237 ) in Salvage Malignant Mesothelioma
- (2020) Carl M. Gay et al. ONCOLOGIST
- Systematic Investigation of the Permeability of Androgen Receptor PROTACs
- (2020) Duncan E. Scott et al. ACS Medicinal Chemistry Letters
- Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation
- (2020) Craig Donoghue et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC: A promising technology for cancer treatment
- (2020) Xin Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Designing an eEF2K-Targeting PROTAC small molecule that induces apoptosis in MDA-MB-231 cells
- (2020) Yao Liu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PROTACs suppression of GSK-3β, a crucial kinase in neurodegenerative diseases
- (2020) Xueyang Jiang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The therapeutic potential of PROTACs
- (2020) Andrew B. Benowitz et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Discovery of First-In-Class Potent and Selective Tropomyosin Receptor Kinase Degraders
- (2020) Liqun Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Proteolysis-Targeting Chimera Molecules that Selectively Degrade the IRAK3 Pseudokinase
- (2020) Sébastien L. Degorce et al. JOURNAL OF MEDICINAL CHEMISTRY
- Understanding the Metabolism of Proteolysis Targeting Chimeras (PROTACs): The Next Step toward Pharmaceutical Applications
- (2020) Laura Goracci et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis-Targeting Chimera Degrader of PARP1 for Treating Cancers
- (2020) Chaoguo Cao et al. JOURNAL OF MEDICINAL CHEMISTRY
- PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase
- (2020) Bikash Adhikari et al. Nature Chemical Biology
- Simultaneous Inhibition of SIRT2 Deacetylase and Defatty-Acylase Activities via a PROTAC Strategy
- (2020) Jun Young Hong et al. ACS Medicinal Chemistry Letters
- Enhancing intracellular accumulation and target engagement of PROTACs with reversible covalent chemistry
- (2020) Wen-Hao Guo et al. Nature Communications
- Design and pharmaceutical applications of proteolysis-targeting chimeric molecules
- (2020) Yuqing Liang et al. BIOCHEMICAL PHARMACOLOGY
- Targeted degradation of CD147 proteins in melanoma
- (2020) Zhe Zhou et al. BIOORGANIC CHEMISTRY
- The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
- (2020) Markella Konstantinidou et al. ChemMedChem
- Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras
- (2020) Akshay D. Takwale et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of potent small molecule PROTACs targeting mutant EGFR
- (2020) Hong-Yi Zhao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)
- (2020) Fangyuan Cao et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges
- (2020) Shenxin Zeng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- PROTACs to address the challenges facing small molecule inhibitors
- (2020) Pedro Martín-Acosta et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Small-Molecule Inhibitors Directly Targeting KRAS as Anticancer Therapeutics
- (2020) Hao Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of IRAK4-Targeting PROTACs
- (2020) Yun Chen et al. ACS Medicinal Chemistry Letters
- Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion
- (2020) Xiaqiu Qiu et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- The PROTAC technology in drug development
- (2019) Yutian Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- Differential PROTAC substrate specificity dictated by orientation of recruited E3 ligase
- (2019) Blake E. Smith et al. Nature Communications
- Developing potent PROTACs tools for selective degradation of HDAC6 protein
- (2019) Zixuan An et al. Protein & Cell
- A chemical approach for global protein knockdown from mice to non-human primates
- (2019) Xiuyun Sun et al. Cell Discovery
- Targeting the untargetable KRAS in cancer therapy
- (2019) Pingyu Liu et al. Acta Pharmaceutica Sinica B
- Degradation of Bruton’s tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas
- (2019) Yonghui Sun et al. LEUKEMIA
- Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions
- (2019) Johannes Popow et al. JOURNAL OF MEDICINAL CHEMISTRY
- In Silico Modeling of PROTAC-Mediated Ternary Complexes: Validation and Application
- (2019) Michael L. Drummond et al. Journal of Chemical Information and Modeling
- Synthesis of 7-benzylguanosine cap-analogue conjugates for eIF4E targeted degradation
- (2019) Tanpreet Kaur et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Selective Degradation of CDK6 by a Palbociclib Based PROTAC
- (2019) Sandeep Rana et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Development of Dual and Selective Degraders of Cyclin-Dependent Kinases 4 and 6
- (2019) Baishan Jiang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- PROTAC-Mediated Degradation of Bruton’s Tyrosine Kinase Is Inhibited by Covalent Binding
- (2019) Christopher P. Tinworth et al. ACS Chemical Biology
- From Inhibition to Degradation: Targeting the Anti-apoptotic Protein Myeloid Cell Leukemia 1 (MCL1)
- (2019) James William Papatzimas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma
- (2019) Yan Song et al. LEUKEMIA
- Targeted degradation of aberrant tau in frontotemporal dementia patient-derived neuronal cell models
- (2019) M Catarina Silva et al. eLife
- Targeted protein degradation: elements of PROTAC design
- (2019) Stacey-Lynn Paiva et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Small molecule PROTACs in targeted therapy: An emerging strategy to induce protein degradation
- (2019) Meiyang Xi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development of Multifunctional Histone Deacetylase 6 Degraders with Potent Antimyeloma Activity
- (2019) Hao Wu et al. JOURNAL OF MEDICINAL CHEMISTRY
- BAF complex vulnerabilities in cancer demonstrated via structure-based PROTAC design
- (2019) William Farnaby et al. Nature Chemical Biology
- Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16
- (2019) Xiaoyu Zhang et al. Nature Chemical Biology
- Small molecule degraders of the hepatitis C virus protease reduce susceptibility to resistance mutations
- (2019) Mélissanne de Wispelaere et al. Nature Communications
- Development of selective small molecule MDM2 degraders based on nutlin
- (2019) Bo Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Progress on small-molecule proteolysis-targeting chimeras
- (2019) Wenhai Huang et al. Future Medicinal Chemistry
- Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders
- (2019) Shang Su et al. JOURNAL OF MEDICINAL CHEMISTRY
- Simple Structural Modifications Converting a Bona Fide MDM2 PROTAC Degrader into a Molecular Glue Molecule: A Cautionary Tale in the Design of PROTAC Degraders
- (2019) Jiuling Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Proteolysis Targeting Chimeras for the Selective Degradation of Mcl-1/Bcl-2 Derived from Nonselective Target Binding Ligands
- (2019) Ziqian Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Neutrophils deficient in innate suppressor IRAK-M enhances anti-tumor immune responses
- (2019) Yao Zhang et al. MOLECULAR THERAPY
- A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
- (2019) Longchuan Bai et al. CANCER CELL
- Inhibit versus Destroy: Are PROTAC Degraders the Solution to Targeting STAT3?
- (2019) Lisa N. Heppler et al. CANCER CELL
- Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs
- (2019) Hongying Gao et al. ACS Medicinal Chemistry Letters
- Development of a PDEδ-Targeting PROTACs that Impair Lipid Metabolism
- (2019) Michael Winzker et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Development of selective mono or dual PROTAC degrader probe of CDK isoforms
- (2019) Fei Zhou et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeting SHP2 as a promising strategy for cancer immunotherapy
- (2019) Qianqian Liu et al. PHARMACOLOGICAL RESEARCH
- Targeting the C481S Ibrutinib-Resistance Mutation in Bruton’s Tyrosine Kinase Using PROTAC-Mediated Degradation
- (2018) Alexandru D. Buhimschi et al. BIOCHEMISTRY
- PROTACs: An Emerging Targeting Technique for Protein Degradation in Drug Discovery
- (2018) Shanshan Gu et al. BIOESSAYS
- Development of the first small molecule histone deacetylase 6 (HDAC6) degraders
- (2018) Ka Yang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cancer chemoprevention revisited: Cytochrome P450 family 1B1 as a target in the tumor and the microenvironment
- (2018) Gabriele D'Uva et al. CANCER TREATMENT REVIEWS
- PROTAC-induced BTK degradation as a novel therapy for mutated BTK C481S induced ibrutinib-resistant B-cell malignancies
- (2018) Yonghui Sun et al. CELL RESEARCH
- Proteolysis Targeting Chimeras (PROTACs) of Anaplastic Lymphoma Kinase (ALK)
- (2018) Chengwei Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Phthalimide conjugations for the degradation of oncogenic PI3K
- (2018) Wenlu Li et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics
- (2018) Yin P Hung et al. HISTOPATHOLOGY
- Chemically Induced Degradation of Anaplastic Lymphoma Kinase (ALK)
- (2018) Chelsea E. Powell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Demonstrating In-Cell Target Engagement Using a Pirin Protein Degradation Probe (CCT367766)
- (2018) Nicola E. A. Chessum et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of QCA570 as an Exceptionally Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of the Bromodomain and Extra-Terminal (BET) Proteins Capable of Inducing Complete and Durable Tumor Regression
- (2018) Chong Qin et al. JOURNAL OF MEDICINAL CHEMISTRY
- 3-Fluoro-4-hydroxyprolines: Synthesis, Conformational Analysis, and Stereoselective Recognition by the VHL E3 Ubiquitin Ligase for Targeted Protein Degradation
- (2018) Andrea Testa et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- The dTAG system for immediate and target-specific protein degradation
- (2018) Behnam Nabet et al. Nature Chemical Biology
- Plasticity in binding confers selectivity in ligand-induced protein degradation
- (2018) Radosław P. Nowak et al. Nature Chemical Biology
- Delineating the role of cooperativity in the design of potent PROTACs for BTK
- (2018) Adelajda Zorba et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8
- (2018) John M. Hatcher et al. ACS Medicinal Chemistry Letters
- Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations
- (2018) Jun Gong et al. Journal for ImmunoTherapy of Cancer
- Modulating PCAF/GCN5 Immune Cell Function through a PROTAC Approach
- (2018) Zuni I. Bassi et al. ACS Chemical Biology
- Discovery of Wogonin-based PROTACs against CDK9 and capable of achieving antitumor activity
- (2018) Jinlei Bian et al. BIOORGANIC CHEMISTRY
- Chemically induced degradation of CK2 by proteolysis targeting chimeras based on a ubiquitin–proteasome pathway
- (2018) Hong Chen et al. BIOORGANIC CHEMISTRY
- Recent advances in small molecule based cancer immunotherapy
- (2018) Binbin Cheng et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Potent Activity of the Bromodomain Inhibitor OTX015 in Multiple Myeloma
- (2018) Jixiang Shi et al. MOLECULAR PHARMACEUTICS
- Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs
- (2018) Sainan An et al. EBioMedicine
- Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
- (2018) William McCoull et al. ACS Chemical Biology
- Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
- (2018) Solomon Tadesse et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of MD-224 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression
- (2018) Yangbing Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemically Induced Degradation of Sirtuin 2 (Sirt2) by a Proteolysis Targeting Chimera (PROTAC) Based on Sirtuin Rearranging Ligands (SirReals)
- (2017) Matthias Schiedel et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation
- (2017) Calla M Olson et al. Nature Chemical Biology
- Structural basis of PROTAC cooperative recognition for selective protein degradation
- (2017) Morgan S Gadd et al. Nature Chemical Biology
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy
- (2016) Yogesh A. Sonawane et al. JOURNAL OF MEDICINAL CHEMISTRY
- FAK Expression, Not Kinase Activity, Is a Key Mediator of Thyroid Tumorigenesis and Protumorigenic Processes
- (2016) B. E. Kessler et al. MOLECULAR CANCER RESEARCH
- Targeting EZH2 in cancer
- (2016) Kimberly H Kim et al. NATURE MEDICINE
- Targeting WEE1 Kinase in Cancer
- (2016) Christopher J. Matheson et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer
- (2016) Narsis Attar et al. Cold Spring Harbor Perspectives in Medicine
- Protein Degradation by In-Cell Self-Assembly of Proteolysis Targeting Chimeras
- (2016) Honorine Lebraud et al. ACS Central Science
- Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
- (2015) Ashton C. Lai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Basigin (CD147), a multifunctional transmembrane glycoprotein with various binding partners
- (2015) Takashi Muramatsu JOURNAL OF BIOCHEMISTRY
- Catalytic in vivo protein knockdown by small-molecule PROTACs
- (2015) Daniel P Bondeson et al. Nature Chemical Biology
- SLC transporters as therapeutic targets: emerging opportunities
- (2015) Lawrence Lin et al. NATURE REVIEWS DRUG DISCOVERY
- Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease
- (2015) Mojtaba Golpich et al. PHARMACOLOGICAL RESEARCH
- Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
- (2015) Eleonore Beurel et al. PHARMACOLOGY & THERAPEUTICS
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Synergy in activating class I PI3Ks
- (2015) John E. Burke et al. TRENDS IN BIOCHEMICAL SCIENCES
- (R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors
- (2015) Ha-Soon Choi et al. ACS Medicinal Chemistry Letters
- Targeting CDK4 and CDK6: From Discovery to Therapy
- (2015) C. J. Sherr et al. Cancer Discovery
- The Role of Histone Acetyltransferases in Normal and Malignant Hematopoiesis
- (2015) Xiao-Jian Sun et al. Frontiers in Oncology
- Eukaryotic elongation factor-2 kinase (eEF2K): a potential therapeutic target in cancer
- (2014) L. L. Fu et al. APOPTOSIS
- BET bromodomain inhibitors—A novel epigenetic approach in castration-resistant prostate cancer
- (2014) Sarah E Lochrin et al. CANCER BIOLOGY & THERAPY
- RIP kinases: key decision makers in cell death and innate immunity
- (2014) F Humphries et al. CELL DEATH AND DIFFERENTIATION
- Discovery of Potent and Selective Sirtuin 2 (SIRT2) Inhibitors Using a Fragment-Based Approach
- (2014) Huaqing Cui et al. JOURNAL OF MEDICINAL CHEMISTRY
- Recent Advances in the Discovery of Small Molecule Inhibitors of Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) as a Therapeutic Target for Inflammation and Oncology Disorders
- (2014) Divya Chaudhary et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
- (2014) Katrina J. Falkenberg et al. NATURE REVIEWS DRUG DISCOVERY
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- TRKing Down an Old Oncogene in a New Era of Targeted Therapy
- (2014) Aria Vaishnavi et al. Cancer Discovery
- SIRT1 and SIRT2: emerging targets in neurodegeneration
- (2013) Gizem Donmez et al. EMBO Molecular Medicine
- Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
- (2013) Cigall Kadoch et al. NATURE GENETICS
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
- (2013) Peter E. Czabotar et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pirin is an iron-dependent redox regulator of NF- B
- (2013) F. Liu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ubiquitin-Binding Proteins: Decoders of Ubiquitin-Mediated Cellular Functions
- (2012) Koraljka Husnjak et al. Annual Review of Biochemistry
- Identification of autophosphorylation sites in eukaryotic elongation factor-2 kinase
- (2012) Sébastien Pyr Dit Ruys et al. BIOCHEMICAL JOURNAL
- Tryptophan Catabolism in Cancer: Beyond IDO and Tryptophan Depletion
- (2012) M. Platten et al. CANCER RESEARCH
- Identification of Anaplastic Lymphoma Kinase as a Potential Therapeutic Target in Ovarian Cancer
- (2012) H. Ren et al. CANCER RESEARCH
- Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
- (2012) Samuel James Matthews et al. CLINICAL THERAPEUTICS
- Cap-Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target
- (2012) Yan Jia et al. MEDICINAL RESEARCH REVIEWS
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- ERK1/2 MAP kinases: Structure, function, and regulation
- (2012) Robert Roskoski PHARMACOLOGICAL RESEARCH
- The Polycomb complex PRC2 and its mark in life
- (2011) Raphaël Margueron et al. NATURE
- Genetic analysis of specific and redundant roles for p38 and p38 MAPKs during mouse development
- (2011) I. del Barco Barrantes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mechanisms and functions of p38 MAPK signalling
- (2010) Ana Cuadrado et al. BIOCHEMICAL JOURNAL
- FLT3 as a therapeutic target in AML: still challenging after all these years
- (2010) T. Kindler et al. BLOOD
- A retroviral vector common integration site between leupaxin and zinc finger protein 91 (ZFP91) observed in baboon hematopoietic repopulating cells
- (2010) Hans-Peter Kiem et al. EXPERIMENTAL HEMATOLOGY
- Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
- (2010) Dana V. Ferraris JOURNAL OF MEDICINAL CHEMISTRY
- Protein Knockdown Using Methyl Bestatin−Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
- (2010) Yukihiro Itoh et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Renal cell carcinoma with novel VCL–ALK fusion: new representative of ALK-associated tumor spectrum
- (2010) Larisa V Debelenko et al. MODERN PATHOLOGY
- Protacs for Treatment of Cancer
- (2010) Kathleen M Sakamoto PEDIATRIC RESEARCH
- Bruton’s tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain
- (2009) Abdalla J. Mohamed et al. IMMUNOLOGICAL REVIEWS
- Inhibition of the Insulin-like Growth Factor-1 Receptor (IGF1R) Tyrosine Kinase as a Novel Cancer Therapy Approach
- (2009) Rongshi Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tubulin-Interactive Natural Products as Anticancer Agents(1)
- (2009) David G. I. Kingston JOURNAL OF NATURAL PRODUCTS
- Bcl6 Mediates the Development of T Follicular Helper Cells
- (2009) R. I. Nurieva et al. SCIENCE
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
- (2008) Ashley R. Schneekloth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- ABT-263: A Potent and Orally Bioavailable Bcl-2 Family Inhibitor
- (2008) C. Tse et al. CANCER RESEARCH
- Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study
- (2008) Daniel G Healy et al. LANCET NEUROLOGY
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activity
- (2008) Ron Firestein et al. NATURE
- Neuropathological Aspects of Alzheimer Disease, Parkinson Disease and Frontotemporal Dementia
- (2008) Kurt A. Jellinger Neurodegenerative Diseases
- FKBP Family Proteins: Immunophilins with Versatile Biological Functions
- (2008) Cong Bao Kang et al. NEUROSIGNALS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started